Skip to main content

Table 4 Vaccination up to date status in the study population

From: Levels of vaccination coverage among HIV-exposed children in China: a retrospective study

Vaccine Total N UTD n (%) PHIV HEU Unknown
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
P-valuea P-valuea P-valuea
BCG 9883 5041 (51.0) 82 (27.0) 1.00
4 900 (52.6) 3.00 (2.32‒3.88)
 < 0.001
59 (22.6) 0.79 (0.54‒1.16)
0.232
HepB3 9902 7928 (80.1) 155 (50.8) 1.00
7 720 (82.8) 4.65 (3.69‒5.85)
 < 0.001
53 (19.7) 0.24 (0.16‒0.35)
 < 0.001
Polio3 9827 4848 (49.3) 58 (19.1) 1.00
4 758 (51.3) 4.45 (3.33‒5.94)
 < 0.001
32 (12.7) 0.62 (0.39‒0.99)
0.044
MCV 9822 4582 (46.6) 52 (17.1) 1.00
4 504 (48.6) 4.58 (3.39‒6.20)
 < 0.001
26 (10.3) 0.56 (0.34‒0.92)
0.023
DTP3 9821 5257 (53.5) 77 (25.4) 1.00
5 144 (55.5) 3.66 (2.82‒4.76)
 < 0.001
36 (14.3) 0.49 (0.32‒0.76)
0.001
  1. BCG Bacillus-Calmette-Guérin, CI confidence interval, DTP diphtheria-tetanus-pertussis-containing, HEU HIV-exposed uninfected, HIV human immunodeficiency virus, HepB hepatitis B, MCV measles-containing vaccine, N number of children, n number of children with the characteristic, OR odds ratio, PHIV perinatally acquired HIV, children perinatally infected with HIV from mothers, UTD up to date, children were classified as up to date if they had received the recommended dose of vaccines before 12 months of age. – means not applicable
  2. aUnivariate logistic regression
\